Drug profile · INN
azelastine hydrochrloride
ASTEPRO
azelastine hydrochrloride (ASTEPRO) is a histamine h1 receptor antagonist. Route of administration: nasal. Current US regulatory status: approved.
Drug details — azelastine hydrochrloride
- US status
- approved
- Class
- —
- Route
- NASAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
azelastine hydrochrloride (ASTEPRO) is a histamine h1 receptor antagonist. Route of administration: nasal. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is azelastine hydrochrloride?
azelastine hydrochrloride (ASTEPRO) is a histamine h1 receptor antagonist. Route of administration: nasal. Current US regulatory status: approved.
What is the brand name for azelastine hydrochrloride?
ASTEPRO is a marketed brand name for azelastine hydrochrloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of azelastine hydrochrloride?
azelastine hydrochrloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.